These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8726465)
21. Pituitary adenylate cyclase-activating polypeptide prevents cytokine-induced cytotoxicity via inhibition of inducible nitric oxide synthase expression in beta TC cells. Sekiya K; Nagasaki H; Ozaki N; Suzuki A; Miura Y; Oiso Y Biochem Biophys Res Commun; 2000 Nov; 278(1):211-6. PubMed ID: 11071874 [TBL] [Abstract][Full Text] [Related]
22. A repressor in the proximal human inducible nitric oxide synthase promoter modulates transcriptional activation. Pance A; Chantome A; Reveneau S; Bentrari F; Jeannin JF FASEB J; 2002 Apr; 16(6):631-3. PubMed ID: 11919177 [TBL] [Abstract][Full Text] [Related]
23. Human- and mouse-inducible nitric oxide synthase promoters require activation of phosphatidylcholine-specific phospholipase C and NF-kappa B. Spitsin SV; Farber JL; Bertovich M; Moehren G; Koprowski H; Michaels FH Mol Med; 1997 May; 3(5):315-26. PubMed ID: 9205947 [TBL] [Abstract][Full Text] [Related]
24. The human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone. Greenland KJ; Jantke I; Jenatschke S; Bracken KE; Vinson C; Gellersen B Endocrinology; 2000 Feb; 141(2):581-97. PubMed ID: 10650939 [TBL] [Abstract][Full Text] [Related]
25. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Yu Z; Zhang W; Kone BC Biochem J; 2002 Oct; 367(Pt 1):97-105. PubMed ID: 12057007 [TBL] [Abstract][Full Text] [Related]
26. Triggering of peritoneal macrophages with IFN-alpha/beta attenuates the expression of inducible nitric oxide synthase through a decrease in NF-kappaB activation. López-Collazo E; Hortelano S; Rojas A; Boscá L J Immunol; 1998 Mar; 160(6):2889-95. PubMed ID: 9510192 [TBL] [Abstract][Full Text] [Related]
27. Transcriptional basis for the differences in inducible nitric oxide synthase (iNOS) expression between nonmetastatic and metastatic murine melanoma cell lines. Gerecitano J; Perle MA; Vilcek J J Interferon Cytokine Res; 1999 Apr; 19(4):393-405. PubMed ID: 10334391 [TBL] [Abstract][Full Text] [Related]
29. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Ganster RW; Taylor BS; Shao L; Geller DA Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8638-43. PubMed ID: 11438703 [TBL] [Abstract][Full Text] [Related]
30. Identification of the promoter region of human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene. Fukasawa M; Takayama E; Shinomiya N; Okumura A; Rokutanda M; Yamamoto N; Sakakibara R Biochem Biophys Res Commun; 2000 Jan; 267(3):703-8. PubMed ID: 10673355 [TBL] [Abstract][Full Text] [Related]
31. The structure of the promoter region for rat inducible nitric oxide synthase gene. Niwa M; Kawai Y; Nakamura N; Futaki S Life Sci; 1997; 61(5):PL 45-9. PubMed ID: 9247328 [TBL] [Abstract][Full Text] [Related]
32. Upstream NF-kappaB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharide-induced RAW 264.7 macrophages. Kim YM; Lee BS; Yi KY; Paik SG Biochem Biophys Res Commun; 1997 Jul; 236(3):655-60. PubMed ID: 9245708 [TBL] [Abstract][Full Text] [Related]
33. Transcriptional activation of the human inducible nitric-oxide synthase promoter by Kruppel-like factor 6. Warke VG; Nambiar MP; Krishnan S; Tenbrock K; Geller DA; Koritschoner NP; Atkins JL; Farber DL; Tsokos GC J Biol Chem; 2003 Apr; 278(17):14812-9. PubMed ID: 12590140 [TBL] [Abstract][Full Text] [Related]
34. Dedifferentiated human ventricular cardiac myocytes express inducible nitric oxide synthase mRNA but not protein in response to IL-1, TNF, IFNgamma, and LPS. Luss H; Li RK; Shapiro RA; Tzeng E; McGowan FX; Yoneyama T; Hatakeyama K; Geller DA; Mickle DA; Simmons RL; Billiar TR J Mol Cell Cardiol; 1997 Apr; 29(4):1153-65. PubMed ID: 9160867 [TBL] [Abstract][Full Text] [Related]
35. Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. Wang B; Ma L; Tao X; Lipsky PE Arthritis Rheum; 2004 Sep; 50(9):2995-303. PubMed ID: 15457469 [TBL] [Abstract][Full Text] [Related]
36. Structural diversity in the 5'-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA. Chu SC; Wu HP; Banks TC; Eissa NT; Moss J J Biol Chem; 1995 May; 270(18):10625-30. PubMed ID: 7537735 [TBL] [Abstract][Full Text] [Related]
37. A SP1 binding site in the GC-rich region is essential for a core promoter activity of the human endothelial nitric oxide synthase gene. Wariishi S; Miyahara K; Toda K; Ogoshi S; Doi Y; Ohnishi S; Mitsui Y; Yui Y; Kawai C; Shizuta Y Biochem Biophys Res Commun; 1995 Nov; 216(2):729-35. PubMed ID: 7488171 [TBL] [Abstract][Full Text] [Related]
38. Effect of cAMP on inducible nitric oxide synthase gene expression: its dual and cell-specific functions. Okado-Matsumoto A; Matsumoto A; Fujii J; Taniguchi N Antioxid Redox Signal; 2000; 2(4):631-42. PubMed ID: 11213468 [TBL] [Abstract][Full Text] [Related]
39. Modulatory effects of progesterone on inducible nitric oxide synthase expression in vivo and in vitro. Coughlan T; Gibson C; Murphy S J Neurochem; 2005 May; 93(4):932-42. PubMed ID: 15857396 [TBL] [Abstract][Full Text] [Related]
40. Neuronal isoform of nitric oxide synthase is expressed at low levels in human retina. Park CS; Gianotti C; Park R; Krishna G Cell Mol Neurobiol; 1996 Aug; 16(4):499-515. PubMed ID: 8879752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]